Archives

On Saturday 15 October, SIRIC ILIAD was present at the National Information Day on Multiple Myeloma (JNM 2022) of the AF3M (French Association of Multiple Myeloma Patients) in Nantes. For the [...]

What if acting on the cells surrounding the tumour could improve the effectiveness of treatments? On 14 September 2022, a team from the SIRIC ILIAD specialising in breast cancer published a [...]

The SIRIC ILIAD Partners Committee met on Monday 17 October 2022 to present the results of the 5 years of labelling. A week ago, the fifth meeting of the SIRIC ILIAD Partners Committee took place [...]

The French National Cancer Institute is organising a day of debate and exchange for the general public on the issue of maintaining and returning to work for people affected by cancer: [...]

Last August, Professor Philippe Moreau, haematologist and director of SIRIC ILIAD, published a scientific article in the prestigious New England Journal of Medicine, alongside some thirty [...]